Johnson & Johnson (JNJ) vs Meta Platforms, Inc. (META)
A side-by-side comparison of Johnson & Johnson and Meta Platforms, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: JNJ is classified in Healthcare; META is classified in Communication Services. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
JNJ
Johnson & Johnson
$266.73HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
META
Meta Platforms, Inc.
$593.41Communication ServicesDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — JNJ vs META
growth of $100 · dividends reinvested · last 14yJNJ +525.3%META +1470.4%META compounded faster
JNJ META
JNJ vs META: by the numbers
- •META is the larger company ($1.51T vs $642.79B market cap).
- •META trades at the lower trailing earnings multiple (21.60 vs 30.82 P/E), one valuation lens rather than an overall verdict.
- •META converts more revenue to profit (32.84% vs 21.48% net margin).
- •META grew revenue faster over the past five years (17.89% vs 2.93% CAGR).
- •JNJ pays the higher dividend yield (1.97% vs 0.35%).
Metrics side by side
Valuation
| Metric | JNJ | META |
|---|---|---|
| P/E ratio | 30.82 | 21.60 |
| Forward P/E | 22.76 | 18.03 |
| P/S ratio | 6.63 | 7.08 |
| P/B ratio | 7.64 | 6.25 |
| PEG ratio | 0.21 | 1.16 |
| EV / EBITDA | 19.98 | 14.51 |
| FCF yield | 3.48% | 3.17% |
Profitability
| Metric | JNJ | META |
|---|---|---|
| Gross margin | 70.45% | 81.94% |
| Operating margin | 26.81% | 41.21% |
| Net margin | 21.48% | 32.84% |
| ROE | 24.76% | 28.97% |
| ROIC | 13.71% | 17.95% |
Dividends
| Metric | JNJ | META |
|---|---|---|
| Dividend yield | 1.97% | 0.35% |
| Payout ratio | 47.51% | 8.76% |
Growth (annualized)
| Metric | JNJ | META |
|---|---|---|
| Revenue CAGR (5Y) | 2.93% | 17.89% |
| EPS CAGR (5Y) | 11.51% | 18.60% |
| FCF CAGR (5Y) | -0.49% | 14.84% |
| Total return CAGR (5Y) | 12.13% | 10.03% |
Frequently asked
- Which has the lower trailing P/E, JNJ or META?
- META has the lower trailing P/E: JNJ trades at 30.82 and META at 21.60. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, JNJ or META?
- Over the past five years, META grew revenue faster — JNJ at a 2.93% CAGR versus META at 17.89%.
- Does JNJ or META pay a bigger dividend?
- JNJ yields 1.97% and META yields 0.35% based on trailing dividends and the latest price.
- Is JNJ or META more profitable?
- META runs the higher net margin — JNJ at 21.48% versus META at 32.84%.
- How have JNJ and META total returns compared?
- Over the past 10 years, JNJ delivered 10.85% and META delivered 17.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Johnson & Johnson P/E ratioMeta Platforms P/E ratioJohnson & Johnson dividend yieldMeta Platforms dividend yieldJohnson & Johnson ROEMeta Platforms ROEJohnson & Johnson operating marginMeta Platforms operating marginJohnson & Johnson revenue growthMeta Platforms revenue growthJohnson & Johnson free cash flowMeta Platforms free cash flow
Johnson & Johnson & Meta Platforms appear in these rankings
25+ Year Dividend GrowersFastest Revenue Growth StocksHighest ROE StocksHighest Operating Margin Stocks
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.